Multiple analysts initiated Buy ratings on Lineage, citing its strong acquisition track record and technological investments. Analysts project high single-digit growth in AFFO and EBITDA for Lineage ...
Ratings for Lineage Cell Therapeutics (AMEX:LCTX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of ...
In the latest quarter, 7 analysts provided ratings for Lineage (NASDAQ:LINE), showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, ...
Cold storage leader Lineage just had the biggest IPO of 2024. It boasts a valuation of $19 billion, Bloomberg reported. Once obscure, cold storage has grown in demand in recent years. Cold-storage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results